Company Description
Whether a heart goes boom-boom, pitter-patter, or is just a-flutter, Cardium Therapeutics is interested in keeping it going strong. The company's...
Key Cardium Therapeutics Financials
| Company Type | Public - OTC: CDTP Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $1.6 |
| Employees | -- |
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Cardium Therapeutics's competition across multiple industries
Top Cardium Therapeutics Competitors
Sponsored Links
The Business Directory
Cardium Therapeutics Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, President, CEO, and Treasurer | Christopher J. Reinhard | Network | E-mail |
| CFO | Dennis M. Mulroy | Network | E-mail |
| EVP, Chief Business Officer, General Counsel, Secretary, and Director | Tyler M. Dylan | Network | E-mail |
More Cardium Therapeutics Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Cardium Therapeutics News
- Cardium Reports on Second Quarter 2008 Highlights and Financial Results [Diabetes Week] (25 Aug 2008 00:01:00 EDT)
- Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities [Diabetes Week] (11 Aug 2008 00:01:00 EDT)
- BioWorld Today August 8, 2008 [BioWorld Today] (08 Aug 2008 00:01:00 EDT)
Sponsored Opportunity
